C07K 5/0202
Containing the structure -nh-x-x-c-, x being an optionally substituted carbon atom or
Official title: {containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids}
C07K5/0202 (Containing the structure -nh-x-x-c-, x being an optionally substituted carbon atom or) appears on 545 US grants and 411 published applications in this corpus.
Search patents in C07K- Granted patents
- 545
- Published applications
- 411
- Assignees
- 290
- Inventors
- 1,471
- Latest grant
- 5 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 3 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 4 | 0 |
| 1983 | 3 | 0 |
| 1984 | 3 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 3 | 0 |
| 1991 | 5 | 0 |
| 1992 | 6 | 0 |
| 1993 | 6 | 0 |
| 1994 | 13 | 0 |
| 1995 | 19 | 0 |
| 1996 | 23 | 0 |
| 1997 | 31 | 0 |
| 1998 | 27 | 0 |
| 1999 | 30 | 0 |
| 2000 | 29 | 0 |
| 2001 | 39 | 6 |
| 2002 | 20 | 35 |
| 2003 | 26 | 25 |
| 2004 | 19 | 25 |
| 2005 | 13 | 23 |
| 2006 | 15 | 22 |
| 2007 | 17 | 20 |
| 2008 | 18 | 12 |
| 2009 | 9 | 9 |
| 2010 | 13 | 18 |
| 2011 | 7 | 14 |
| 2012 | 15 | 10 |
| 2013 | 10 | 23 |
| 2014 | 13 | 13 |
| 2015 | 10 | 19 |
| 2016 | 13 | 20 |
| 2017 | 11 | 22 |
| 2018 | 6 | 15 |
| 2019 | 17 | 11 |
| 2020 | 12 | 19 |
| 2021 | 12 | 5 |
| 2022 | 5 | 8 |
| 2023 | 5 | 9 |
| 2024 | 6 | 15 |
| 2025 | 1 | 9 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Modified enzyme and method of producing imidazole dipeptide using same5 May 2026US 12,618,056 B2Ajinomoto Co., Inc.
- Targeted plasma protein degradation21 Apr 2026US 12,605,451 B2Novartis AG
- Method for producing peptide compound4 Mar 2025US 12,240,871 B2Nissan Chemical Corporation
- Reagents for quantitative mass spectrometry26 Nov 2024US 12,153,051 B2Dana-Farber Cancer Institute, Inc.
- Somatostatin subtype-2 receptor (SST2R) targeted therapeutics and uses thereof5 Nov 2024US 12,134,610 B2Crinetics Pharmaceuticals, Inc.
- Ptp1b/tc-ptp dual inhibitors and protein degraders20 Aug 2026US 2026/0240878 A1Purdue Research Foundation
- Compounds, linker units comprising the same, and uses thereof in treating diseases18 Jun 2026US 2026/0167669 A1T-E Meds Inc.
- Beta-peptides and beta-peptide hydrogels23 Apr 2026US 2026/0108612 A1Monash University
- Compounds and Their Use in Filtering Ultraviolet and/or High-Energy Visible Light9 Apr 2026US 2026/0098007 A1Soliome Inc.
- Compound and labeled biological substance using the same25 Dec 2025US 2025/0389724 A1FUJIFILM Corporation
Most cited
By later US patents
- Pentapeptide compounds and uses related thereto298US 6,884,869 B2Seattle Genetics, Inc. · 2005
- Branched peptide linkers136US 6,759,509 B1Bristol-Myers Squibb Company · 2004
- Lipid conjugates of therapeutic peptides and protease inhibitors130US 5,554,728 ANeXstar Pharmaceuticals, Inc. · 1996
- Inhibitors of interleukin-1.beta. converting enzyme104US 5,756,466 AVertex Pharmaceuticals Incorporated · 1998
- Inhibitors of interleukin-1β converting enzyme101US 6,350,741 B1Vertex Pharmaceutical Incorporated · 2002